Jenny Robertson

• Maintain investor and partner confidence by aligning regulatory pivots with disciplined communications
• Protect timelines and budgets by responding decisively to CRLs, endpoint shifts, and evolving agency expectations
• Strengthen resilience by leveraging patient advocacy, public affairs, and cross-functional escalation pathways during  periods of agency uncertainty

Reduce legal and ethical exposure through validated guardrails and approval processes

Empower teams to adopt AI confidently without breaching policy or regulatory expectations

Prevent misuse with monitoring, access controls, and cross-functional oversight, while accounting for emerging differences  between federal guidance and state-level AI regulations